A 58-year-old man presents with painless progressive jaundice, pale stools, and dark urine for 3 weeks. Imaging shows a dilated common bile duct (12 mm) with a distal stricture suspicious for pancreatic head malignancy. He is scheduled for ERCP. Which drug should be administered prophylactically before the procedure to reduce the risk of post-ERCP pancreatitis?